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Abstract
 
Long-term cultured pre-B cells are able to differentiate into immunoglobulin (Ig)M-positive B
cells (IgM
 

 
 cells) when transplanted into severe combined immunodeficient (SCID) mice.
Based on previous studies, here we report the development of a reconstitution assay in non-
obese diabetic/SCID (NOD/SCID) mice using pre-B cells, which allows us to study the role
of calpains (calcium-activated endopeptidases) during B cell development as well as in B cell
clonal deletion. Using this model, we show that calpastatin (the natural inhibitor of calpains)
inhibits B cell receptor–induced apoptosis in IgM
 

 
 cells derived from transplanted mice. We
thus hypothesize an important function for calpain in sculpting the B cell repertoire.
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Introduction
 
Several steps are essential for hematopoietic stem cell differ-
entiation to mature B cells (1). Progenitor B cells (pro-B
cells, identified by acquisition of B-220, CD43, and c-kit)
 
can rearrange D
 
H
 
 to J
 
H
 
 segments in the Ig heavy chain locus
and are then termed pre-BI cells. Maturation of pre-BI cells
 
occurs when V
 
H
 
 and DJ
 
H
 
 segments join; the 
 

 
H chain ap-
pears in cytoplasm and assembles with the products of the
 

 
5 and V pre-B genes. This mechanism leads to acquisition
 
of the pre-B cell receptor (pre-BCR);
 
*
 
 at this stage, B cells
are called pre-BII cells and become c-kit- and CD43 nega-
tive. Later in B cell development, rearrangement begins
again, now in the Ig light chain locus; B cells thus express a
complete surface IgM molecule and are then denominated
immature B cells (1). As the mechanisms that mediate IgH
and IgL gene recombination are error prone, a large pro-
portion of B cell precursors fails to express functional IgH
and IgL molecules. Those with nonproductive rearrange-
ments die in situ by apoptosis at the pre-BI to pre-BII tran-
sition, as they do not receive a survival signal (2).
Another consequence of random V(D)J recombination is
the generation of B cells that recognize endogenous self-
antigens (3). To avoid autoimmune manifestations, an im-
portant mechanism allows the elimination of self-reactive B
cells via apoptosis (clonal deletion [3]). The apoptotic pro-
cess is executed by a group of proteases including caspases
(cysteinyl aspartate-specific proteinases) and calpains (cal-
cium-activated proteases [4]). Implication of both caspases
and calpains during B cell clonal deletion have been dem-
onstrated in immature B cells (5–7); nevertheless, the bio-
chemical events leading to apoptosis by the BCR are not
entirely clear.
B cell development is controlled by IL-7, as indicated by
analysis of IL-7 knockout mice (8). Pre-B cells can be cul-
tured
 
 
 
in the presence of IL-7 (9); when transplanted into
SCID mice, these cells differentiate into IgM-positive B
cells (IgM
 

 
 cells [10]). Based on these studies, we developed
a reconstitution assay by transplanting long-term cultured
pre-B cells in nonobese diabetic/SCID (NOD/SCID)
mice, which lack innate and adaptive immunity (11). To
track the transplanted pre-B cells in vivo, we transduced
them by infection with a Moloney murine leukemia virus
retroviral vector (pLZR-IRES/GFP). This vector contains
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the green fluorescence protein (GFP) under the control of
an internal ribosome entry site (IRES), which allows in vivo
study of the evolution of these cells. This model thus served
to analyze the role of calpains during the B cell differentia-
tion process as well as during B cell clonal deletion. Here
we demonstrate that calpastatin (the natural inhibitor of
calpains) did not interfere with B cell differentiation in the
reconstitution model; however, IgM
 

 
 cells expressing calpa-
statin showed intrinsic resistance to BCR-induced apopto-
sis. We therefore conclude that calpain has an important
function in B cell clonal deletion and in establishing the B
cell repertoire.
 
Materials and Methods
 
Cell Culture and Animal Facility.
 
WEHI-231 immature B
cells were cultured in RPMI-1640 (BioWhittaker) supple-
mented with 10% FCS, 2 mM 
 
l
 
-glutamine, 10 U/ml penicillin,
10 
 

 
g/ml streptomycin, 10 mM HEPES, and 50 
 

 
M 2-mercap-
toethanol (Sigma-Aldrich) and maintained at 37
 

 
C in a humidi-
fied atmosphere with 5% CO
 
2
 
. Pre-BI cells were derived from
adult BALB/c mouse bone marrow (BM), and cultured in
IMDM supplemented with 10 U/ml penicillin, 10 
 

 
g/ml strep-
tomycin, 1 mM sodium pyruvate, nonessential amino acids, 50
 

 
M 2-mercaptoethanol, 2 mM 
 
l
 
-glutamine, 10% FCS, and 3%
supernatant from a murine IL-7–producing cell line. IgM
 

 
/
mock, IgM
 

 
/GFP, and IgM
 

 
/calpastatin cells were derived
from NOD/SCID mice 2 mo after transplantation and single cell
suspensions were prepared from BM. BM cells were flushed
from femurs and tibiae and cultured in IMDM supplemented
with 10 U/ml penicillin, 2 mM/ml 
 
l
 
-glutamine, 10% FCS, and
3% supernatant from a murine IL-7–producing cell line. After
2 d in culture, suspension-growing cells were separated from BM
adherent cells. Suspension cells were transferred to new plates in
the same medium. Under these conditions, differentiated IgM
 

 
cells proliferate for several weeks in the presence of IL-7 (data
not shown). Male and female NOD-Lt/Sz-
 
scid
 
/
 
scid
 
 (NOD/
SCID) mice, bred in our animal facility, were used at 4 to 6 wk
of age. All experiments were performed in compliance with
norms of our animal facility committee.
 
Antibodies and Reagents.
 
Goat anti–mouse IgM, 
 

 
 chain spe-
cific (10 
 

 
g/ml; Jackson ImmunoResearch Laboratories) was
used to induce apoptosis. To confirm calpastatin expression, we
used goat anti-calpastatin (R-19; Santa Cruz Biotechnology,
Inc.). For staining analysis, the following biotin-conjugated anti-
bodies were used: anti-B220 (clone RA3-6B2), anti-CD43 (S7),
anti-CD19 (1D3), anti-CD3 
 

 
 chain (145-2C11), anti-Ter-119
(TER-119) and anti-Mac-1 (M1/70), anti-CD21 (7G6), anti-
CD23 (B3B4), and anti-CD25 (7D4) (all from BD PharMingen);
affinity-purified goat anti-IgM (
 

 
 chain-specific), and anti-IgD (
 

 
chain-specific; SBA-1) (both from Southern Biotechnology Asso-
ciates, Inc.). Streptavidin-SpectralRed (SPRD) was from South-
ern Biotechnology Associates, Inc. Actinomycin D (Act-D) was
purchased from Sigma-Aldrich.
 
Flow Cytometry Analysis for Marker Expression.
 
Cells were
washed in PBS containing 2% FCS and 0.1% NaN
 
3
 
 (staining
PBS), incubated with biotin-conjugated antibodies (20 min, on
ice), then washed with staining PBS, incubated with streptavidin-
SPRD, and analyzed on an EPICS XL flow cytometer (Beckman
Coulter).
 
Assessment of Apoptotic Cell Death.
 
Apoptosis was evaluated
by staining cellular DNA with the DNA intercalator propidium
iodide (PI) using a semiautomatic procedure (DNA-Prep Re-
agents; Beckman Coulter), followed by analysis on an EPICS XL
flow cytometer. In brief, cells (10
 
5
 
–10
 
6
 
) were recovered by cen-
trifugation, resuspended in 100 
 

 
l of PBS, then permeabilized
and stained by addition of 100 
 

 
l of detergent reagent followed
by 1 ml of PI solution. After mixing, samples were incubated
(37
 

 
C, 30 min) and analyzed in flow cytometry. Apoptosis was
determined as the percentage of DNA located in the hypoploid
subG
 
0
 
/G
 
1
 
 peak of the cell cycle.
 
Western Blot Analysis.
 
Cells (10
 
6
 
) were collected, washed
with ice-cold PBS, and resuspended in RIPA lysis buffer (20 mM
Tris-HCl, pH 8, 137 mM NaCl, 1 mM MgCl
 
2
 
, 1 mM CaCl
 
2
 
,
10% glycerol, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, and
protease inhibitors). Lysate protein content was quantified using
the DC protein assay (Bio-Rad Laboratories). After SDS-PAGE
under reducing conditions, proteins were transferred to nitrocel-
lulose membranes (Bio-Rad Laboratories), which were blocked
overnight with 5% nonfat dry milk in TBS buffer (20 mM Tris-
HCl, pH 7.5, 150 mM NaCl). Subsequent antibody incubations
and membrane washes were performed in TBS-T buffer (20 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Tween 20) containing
1% nonfat milk. After 2 h, antibody incubation and washing,
PO-conjugated anti–goat was added for 1 h. Blots were washed
extensively and developed using the enhanced chemolumines-
cence (ECL) system (Amersham Pharmacia Biotech).
 
Cloning of Calpastatin and Retroviral Transduction.
 
We used a
Moloney murine leukemia virus–based retroviral vector (pLZR-
IRES/GFP), which was obtained from the pLZR-CMV-gfp
plasmid (12) by replacing the enhanced GFP (EGFP) sequence
with the IRES/gfp cassette from plasmid pIRES2/EGFP
(CLONTECH Laboratories, Inc.). Murine calpastatin cDNA
(13) was cloned into the EcoRI site of the pLZR-IRES/GFP
vector to generate a pLZR-calpastatin/IRES/GFP construct.
GFP
 

 
 cells were monitored and sorted in a Beckman Coulter
EPICS Altra Hypersort. Retrovirus was produced by transient
transfection of 293T cells (12, 14). For viral transduction, 10
 
5
 
cells (WEHI-231 or pre-BI cells) were incubated 4 h with 5 
 

 
g/
ml of protamine sulphate (Sigma-Aldrich) in 1 ml of retroviral
supernatant or in virus-free medium. Infection was performed at
37
 

 
C and repeated 24 h later under the same conditions.
 
Calcium Determination.
 
Changes in intracellular Ca
 
2
 

 
 concen-
tration were monitored using the fluorescent probe Indol-AM
(Molecular Probes). Cells (10
 
7
 
/ml) were washed three times in
HBB buffer (1
 
 
 
Hank’s balanced salt solution, 0.1% BSA, and 10
mM Hepes, pH 7.5), then incubated with 3 
 

 
M Indol-AM (30
min, 37
 

 
C). After incubation, cells were washed and resuspended
at 0.8 
 

 
 10
 
6
 
 cells/ml in HBB buffer, then maintained at 4
 

 
C until
anti-IgM addition. Calcium mobilization in response to 10 
 

 
g/
ml of anti-IgM was determined at 37
 

 
C by fluorimetry.
 
Results
 
Calpastatin Prevents BCR-induced Apoptosis in the WEHI-
231 Immature B Cell Line.
 
The immature B cell WEHI-
231 has been used as a model for B cell tolerance based on
its phenotype (sIgM
 
high
 
sIgD
 
low
 
), which parallels that of im-
mature B cells. Although many early signal transduction
events through the BCR have now been elucidated, the
biochemical events leading to apoptosis are not entirely
clear. Molecular dissection of the mechanisms and bio-
chemical pathways involved in these changes showed that
calpain activation has an important role in the apoptotic ma-
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chinery (6, 7). The best-characterized calpains are the ubiq-
uitously expressed calpain-1 and calpain-2 (also called cata-
lytic subunits), which are activated by calcium (15). Calpain
activity can be regulated by a p30 regulatory subunit with
chaperone-like effects on the refolding of the catalytic sub-
units (16, 17), and by calpastatin, which inhibits calpain ac-
tivation by interacting with both the active site and the
calmodulin-like Ca
 
2
 

 
-binding domain of calpains (18).
To study the role of calpains during BCR-induced ap-
optosis, we expressed calpastatin in WEHI-231 cells. We
transduced them using the pLZR-IRES/GFP retroviral
vector (see Materials and Methods), with GFP under the
control of an IRES (Fig. 1 A); this vector is based on others
described previously. We cloned murine calpastatin cDNA
in the pLZR-IRES/GFP vector to generate a construct
(pLZR-calpastatin/IRES/GFP; Fig. 1 A). WEHI-231 cells
were then transduced by retroviral infection using both
pLZR-IRES/GFP and pLZR-calpastatin/IRES/GFP to
generate WEHI-231/GFP and WEHI-231/calpastatin cells
(see Materials and Methods); cells were monitored and
sorted (see Materials and Methods). After sorting, Western
blot analysis for calpastatin expression was performed using
total extracts from WEHI-231/GFP and WEHI-231/calpa-
statin cells, as well as from nontransduced WEHI-231 cells
(WEHI-231/mock cells; Fig. 1 B). Apoptosis analysis of
these cells showed that calpastatin inhibited BCR-induced
apoptosis (Fig. 1 C), confirming the implication of calpains
in anti-IgM–induced apoptosis. To clarify whether calpa-
statin has a general survival effect on WEHI-231 cells, we
treated them with Act-D, which induces apoptosis via cy-
tochrome c release from mitochondria. This apoptotic
pathway is not found during anti-IgM–induced apoptosis
in WEHI-231 cells (6). Act-D–induced apoptosis is not
blocked by calpastatin overexpression in these cells (Fig. 1
C), indicating that calpastatin is not a general apoptotic in-
hibitor, but that its inhibitory effect is cell death stimulus
specific. As the presence of autolytic calpain-2 fragments
indicate calpain-2 activation (19, 20), we performed West-
ern blot analysis for calpain-2 (Fig. 1 D). We detect
calpain-2 processing after anti-IgM–induced apoptosis in
Figure 1. Calpastatin expression inhibits anti-IgM–induced apoptosis in WEHI-231 cells. (A) Murine calpastatin cDNA (reference 22) was cloned into
the EcoRI site of the pLZR-IRES/GFP vector to generate the pLZR-calpastatin/IRES/GFP construct. (B) WEHI-231 cells were transduced by retro-
viral infection using pLZR-/IRES/GFP and pLZR-calpastatin/IRES/GFP. GFP cells were monitored in a Beckman Coulter EPICS Altra Hypersort
and analyzed for calpastatin expression. Western blot (WB) analysis was performed using goat anti-calpastatin (R-19) to confirm transgene expression. (C)
WEHI-231/mock, WEHI-231/GFP, and WEHI-231/calpastatin cells were cultured (0.25  106 cells/ml) in medium alone, with goat anti-IgM anti-
body (10 g/ml; 48 h) or with Act-D (1 g/ml; 12 h) for the apoptosis assay. Apoptosis was evaluated by staining cellular DNA. Values represent the
mean of five independent experiments. (D) Western blot analysis for calpain-2 in WEHI-231/mock, WEHI-231/GFP, and WEHI-231/calpastatin cells.
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WEHI-231 cells (Fig. 1 D); nonetheless, calpastatin over-
expression inhibits calpain-2 processing incompletely, or
possibly the cell compensates for the inhibition by produc-
ing additional free calpain-2 (Fig. 1 D). This result may ex-
plain why calpastatin does not block apoptosis completely
in WEHI-231 cells.
 
Calpastatin Expression Does Not inhibit IL-7 Deprivation-
induced Apoptosis in Long-Term Cultured Pre-BI Cells.
 
IL-7
controls the process of hematopoietic stem cell differentia-
tion to mature B cells (1, 8). BM-derived pre-B cells prolif-
erate in vitro in the presence of IL-7, whereas its absence
triggers apoptosis (9). To analyze the role of calpastatin as
an apoptosis inhibitor during IL-7 deprivation-induced ap-
optosis, we derived pre-BI cells from adult BALB/c mouse
BM and cultured them in IL-7. Long-term cultured pre-BI
cells were then transduced by retroviral infection using the
pLZR-IRES/GFP and pLZR-calpastatin/IRES/GFP con-
structs to generate pre-BI/GFP and pre-BI/calpastatin cells.
Cells were monitored and sorted (see Materials and Meth-
ods), after which pre-BI/GFP and pre-BI/calpastatin cells
were cultured in vitro in the presence of IL-7; untrans-
duced pre-BI cells (pre-BI/mock) were used as a control.
Staining analysis for the surface proteins B220, CD43,
and IgM showed that GFP expression in long-term cul-
tured pre-BI cells does not interfere with the pre-BI phe-
 
notype (Fig. 2 A). We observed that long-term cultured
GFP-positive cells gradually lost GFP protein expression
after 2 wk in culture; this effect has been observed in other
cell types in which long-term in vivo expression from the
viral promoter is not completely satisfactory (21, 22). In ad-
dition, pre-BI/calpastatin cells lose more GFP expression
than do pre-BI/GFP cells. Several studies have been con-
ducted to determine the parameters that influence recogni-
tion of the start codon in IRES-dependent translation initi-
ation in bicistronic constructs. These studies show that the
secondary structure of the region that separates the 3
 
	
 
 end
of the IRES element from the initiator codon play an es-
sential role in start codon recognition (23). The insertion of
sequences containing an additional start codon upstream of
the IRES element greatly reduce the translation efficiency
of the second gene, both in vivo and in vitro (24). More-
over, it has been shown that expression of genes upstream
of IRES elements interferes with GFP expression (25, 26).
Here we made a similar observation in pre-BI cells express-
ing calpastatin plus GFP; GFP expression is altered in these
cells by upstream calpastatin expression.
Apoptosis analysis after IL-7 deprivation showed that
calpastatin expression did not block IL-7 deprivation-
induced apoptosis (Fig. 2 B); Western blot analysis for calpa-
statin was performed as an expression control (Fig. 2 B).
Figure 2. Calpastatin expression does not
inhibit IL-7 deprivation-induced apoptosis.
(A) Long-term cultured pre-BI cells were
transduced using pLZR-/IRES/GFP and
pLZR-calpastatin/IRES/GFP. GFP cells
were monitored and sorted. Pre-BI/mock,
pre-BI/GFP, and pre-BI/calpastatin cells (105
each) were collected and washed in ice-cold
PBS. Cells were incubated in 30 l of stain-
ing PBS with biotin-conjugated anti-B220,
anti-IgM, or anti-CD43 antibody, washed, incubated with streptavidin-SPRD, and analyzed on a flow cytometer. (B) Pre-BI/mock, pre-BI/GFP, and
pre-BI/calpastatin cells were cultured (0.25  106 cells/ml) in medium with or without IL-7 for the apoptosis assay. Apoptosis was evaluated by staining
cellular DNA. Values represent the mean of three independent experiments. Western blot (WB) analysis was performed using goat anti-calpastatin to
confirm expression.
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These results, together with those from the WEHI-231
cells, demonstrate the contribution of calpains during
BCR-induced apoptosis, but not during IL-7 deprivation-
induced apoptosis in pre-BI cells.
 
Characterization of the Reconstitution Assay in NOD/SCID
Mice Using Long-Term Cultured Pre-BI Cells.
 
In vitro–cul-
tured pre-BI cells differentiate into IgM
 

 
 cells
 
 
 
when trans-
planted into SCID mice (9, 10). This process is regulated
by expression of the recombinant protein recombination
activating gene (RAG)-2 (27). Using long-term cultured
pre-BI/GFP cells, which allow in vivo cell tracking, we
developed a reconstitution assay in NOD/SCID mice to
confirm the ability of pre-BI cells to differentiate into
IgM
 

 
 cells. Pre-BI/GFP cells (10
 
7
 
 cells) were transplanted
intravenously into 300 Gy-irradiated NOD/SCID mice.
As described previously (10), the dominance of B cell lym-
phopoiesis in BM is detected between 2 and 4 mo after
transplantation (data not shown). Transplanted pre-BI/
GFP cells differentiated into IgM
 

 
 B cells (IgM
 

 
/GFP
cells), which were identified by expression of B220
 

 
,
CD19
 

 
, IgM
 

 
, and the lack of IgD expression (data not
shown). Staining controls for CD3 (for T cells), Mac-1
(macrophages), and Ter-119 (erythrocytes) were negative.
In conclusion, these data confirm the ability of long-term
cultured pre-BI cells to differentiate into IgM
 

 
 cells in BM,
as well as the possibility to track these cells
 
 
 
in vivo.
 
Pre-BI Cells Expressing Calpastatin Differentiate into IgM
 

 
B Cells Showing Impaired Clonal Deletion In Vitro.
 
Expres-
sion of murine calpastatin prevents BCR-induced apoptosis
in WEHI-231 cells, confirming calpain implication during
anti-IgM–induced apoptosis in this model of B cell toler-
ance. We used the reconstitution assay described above to
explore the role of calpain in BCR-triggered apoptotic ma-
chinery. This assay allowed us to study the impact of calpa-
statin expression as an inhibitor of BCR-induced apoptosis
in IgM
 

 
 cells. Pre-BI/mock, pre-BI/GFP, and pre-BI/
calpastatin cells were thus transplanted into NOD/SCID
mice to derive IgM
 

 
/mock, IgM
 

 
/GFP, and IgM
 

 
/calpa-
statin cells (see Materials and Methods). To explore
whether calpastatin expression has an influence on B cell
differentiation, we sorted GFP
 

 
 cells from transplanted
NOD/SCID mice. FACS
 
®
 
 analysis of cells from BM of
transplanted pre-BI/GFP and pre-BI/calpastatin NOD/
SCID mice indicates that calpastatin does not alter B cell
differentiation (Fig. 3). In addition, the results indicate that
B cells obtained from transplanted NOD/SCID mice are
B220
 

 
, IgM, IgD
, CD19, CD25
, CD43, CD21
,
and CD23
. Similar results were found when human
CD34 stem cells were transplanted into NOD/SCID
mice, generating B cells characterized by expression of the
surface markers IgM, IgD
, CD19, CD43
, CD21
,
CD23
, and Mac-1
 (28). Novelli’s group identified these
as B-1 cells using the reciprocal CD23 and CD43 expres-
sion pattern, as B-1 cells are CD23
CD43, whereas B-2
cells are CD23CD43
 (29, 30).
IgM cells from reconstituted NOD/SCID mice ex-
pressed the BCR and calpastatin, even 2 to 3 wk after isola-
tion from marrow (Fig. 4, A and B). As sustained Ca2 in-
Figure 3. Pre-BI/GFP and pre-BI/calpastatin cells differentiate into IgM B cells in NOD/SCID mice. Male and female NOD/SCID mice bred in
our animal facility were used at 3–4 wk of age for transplantation experiments. Representative results (n  12) are shown from BM of pre-BI/GFP and
pre-BI/calpastatin-transplanted NOD/SCID mice. GFP-positive cells (106) from BM sorted by FACS® analysis were stained with biotin-conjugated
anti-B220, anti-IgM, anti-IgD, anti-CD19, anti-CD25, anti-CD43, anti-CD21, or anti-CD23 antibodies. Anti-CD3, anti–Ter-119, and anti–Mac-1
(not shown), as well as streptavidin-SPRD alone were used as controls.
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Figure 4. Calpastatin expression inhibits apoptosis in IgM B cells. (A) Distinct derived IgM/mock (mouse #4), IgM/GFP (#3 and #27), and IgM/
calpastatin (#10 and #11) cells were stained with a biotin-conjugated anti-IgM, anti-B220, or anti-CD43 antibodies, then washed with staining PBS, in-
cubated with streptavidin-SPRD, and analyzed by flow cytometry. Streptavidin-SPRD alone was used as control. In addition, Ca2 influx was measured
as described (see Materials and Methods). (B) Western blot (WB) analysis was performed using goat anti-calpastatin (R-19) to confirm transgene expression
in IgM/mock (#4 and #22), IgM/GFP (#3 and #27), and IgM/calpastatin cells (#10, #11, #20, #31, and #35). (C) IgM/mock, IgM/GFP, and
IgM/calpastatin cells were cultured (0.25  106 cells/ml) in medium alone, with goat anti-IgM antibody (10 g/ml), or in the presence of 1 g/ml of
Act-D for the apoptosis assay. Apoptosis was evaluated by staining cellular DNA. Values are representative of three independent experiments.
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flux is required for calpain activation (18), we tested
whether BCR cross-linking triggered Ca2 influx in de-
rived IgM/mock, IgM/GFP, and IgM/calpastatin cells
(Fig. 4 A). In addition, we analyzed several surface markers
in IgM cells derived from transplanted NOD/SCID mice,
and found no significant differences among IgM/mock,
IgM/GFP, and IgM/calpastatin cell lines (Fig. 4 A).
To validate the role of calpastatin as an inhibitor of
BCR-induced apoptosis, we analyzed apoptosis at 24 and
48 h after anti-IgM cross-linking. IgM/calpastatin cells
presented intrinsic resistance to BCR-induced apoptosis
(Fig. 4 C), confirming calpain implication in this type of
apoptosis, indicating an important function for calpains in
generating the B cell repertoire.
Discussion
Apoptosis is the most common physiological form of cell
death; it occurs during embryonic development, tissue re-
modeling, immune regulation, cell activation, and tumor
regression (31). In the hematopoietic system, B cell genera-
tion is regulated by a negative selection mechanism, by
which B cells undergo a BCR-activated apoptotic process.
The apoptotic machinery is activated when the BCR rec-
ognizes endogenous self antigens or antigens in the absence
of costimulating signals (3). The immature B cell WEHI-
231 has been widely used as a model of B cell tolerance,
based on its capacity to undergo apoptosis after BCR cross-
linking, which induces calpain activation and subsequent
apoptosis (6, 7). Calpain activation triggers destruction of
distinct proteins involved in cell cycle, cytoskeletal model-
ing, cell spreading, as well as multiple transcription factors,
thus causing apoptosis (18); nonetheless, the contribution
of calpains to BCR-induced apoptosis is unknown.
Calpain activation takes place after calcium mobilization,
which is triggered by BCR cross-linking (18, 32). Phos-
pholipase C (PLC-) activation by BCR cross-linking
leads to phospholipid hydrolysis, yielding inositol 1,4,5-tris
phosphate (IP3) and diacylglycerol (DAG). IP3 then binds
IP3 receptors located in the endoplasmic reticulum, causing
Ca2 release from internal stores (32). Modulation of BCR
activation can be mediated by inhibitory receptors such as
FcRII and paired immunoglobulin-like receptor B (PIR-B;
reference 33), whose activation recruits the phosphatase Src
homology 2 domain–containing 5	 inositol phosphatase
(SHIP), which mediates some inhibitory signaling such as
PLC- inhibition and subsequent BCR cross-linking–
induced Ca2 mobilization (33). As a consequence of this
inhibitory mechanism, FcRII and PIR-B stimulation pre-
vent BCR-induced apoptosis.
Calpains are implicated in other apoptotic models such as
TGF-–induced apoptosis in B lymphocytes (34), TCR-
induced apoptosis in thymocytes (35), or neuronal cell
death (36). In neurons, calpain activation induces cleavage
of p35 (a neuron-specific activator of cyclin-dependent ki-
nase 5, cdk5) giving rise to p25, which accumulates in the
brain of patients with Alzheimer’s disease. Conversion of
p35 to p25 causes prolonged activation of cdk5, which hy-
perphosphorylates tau, disrupts the cytoskeleton, and
promotes apoptosis (36). In B cells, however, the calpain-
driven apoptosis mechanism involves processing and subse-
quent activation of caspase-7, indicating the distinct induc-
tion mechanisms induced by calpain activation (6, 7).
Here we analyzed the role of the calpains in B cell clonal
deletion by expressing their natural inhibitor, calpastatin,
to study the contribution of these proteases to this pro-
cess. We demonstrate that calpastatin expression inhibited
BCR-induced apoptosis in WEHI-231 cells, as well as in
IgM B cells from reconstituted NOD/SCID mice. The
inhibition ability of calpastatin is specific for BCR-induced
apoptosis, as calpastatin expression did not block IL-7 dep-
rivation-induced apoptosis in pre-BI cells or Act-D–
induced apoptosis in WEHI-231 cells. These data indicate
the selective ability of calpastatin as an apoptosis inhibitor,
and its capacity to modulate the B cell repertoire by regu-
lating clonal deletion.
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